Conclusions
hand and foot eczema, eczema, pain
ECZEMA
Overall, our intervention had a positive effect on quality of life, pain, activity, and possibly the clinical outcome in a subgroup of patients with hand and foot eczema.We were able to show that a monitoring app for patients with hand and foot eczema that allows direct contact with their treating physicians combined with patient education may have the potential to improve the eczema outcome of these patients, especially if the app is not used too frequently. We believe that a monitoring app such as the one presented in this study has the potential to improve patient care and should be implemented in daily practice. However, because of the small number of participants, especially in the subgroups of the intervention group, as well as missing data on treatment adherence of the control group, these data need to be re-examined in a larger sample with consideration of individual factors.The authors express special thanks to the team of the dermatology department of the University Hospital Mannheim. This work was sponsored by Novartis Pharma GmbH.Conflicts of Interest: AS received honoraria for presentations and as a member of the advisory boards of LEO Pharma, Novartis GmbH, and Almirall Hermal GmbH. AS is the CEO and owner of Derma Intelligence GmbH, which developed DermaScope Mobile.CONSORT-eHEALTH checklist (V 1.6.1).